Acute Respiratory Distress Clinical Trial
Official title:
Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management
Randomized controlled trial of intubation using the C-MAC video laryngoscope versus standard laryngoscopy. Patients who are going to be intubated using standard laryngoscopy will be randomized to have their first intubation attempt done using either standard laryngoscopy or the C-MAC video laryngoscope. Subsequent attempts will be at the discretion of the treating physician.
Experimental Design and Methods:
This will be a prospective randomized controlled trial of intubation using the C-MAC video
laryngoscope versus standard laryngoscopy for patients requiring emergent intubation in the
Emergency Department.
Study Setting and Population:
This study will be performed at an urban county medical center with approximately 97,000
patient visits per year. Adult patients (age >17) requiring intubation will be enrolled.
Study Protocol:
All ED patients who are unable to adequately breathe on their own requiring emergent
intubation for airway management will be screened for inclusion in the study. Identified
patients will be deemed eligible when the need for intubation has been determined by the
treating physician. Eligible patients will be placed on capnograph, cardiac, blood pressure
and pulse oximetry monitors. Patients will be randomly assigned to be intubated using
standard laryngoscopy with the C-MAC blade or C-MAC videolaryngoscope. Sealed envelopes
containing the randomization assignment for the treatment groups will be kept at the
patient's bedside in the stabilization room. Patients will be monitored by oxygen saturation,
blood pressure, heart rate, and respiratory rate, which are typical for patients requiring
intubation in our ED. Data will be recorded every minute by a trained research assistant at
the patient's bedside. The lowest oxygen saturation during the procedure will be recorded for
determination of hypoxia. Hypoxia will be defined as an oxygen saturation <93%. The number of
attempts made to intubate and the total time to successful intubation will be recorded. An
attempt starts when the intubating device enters the patients mouth and ends when the
endotracheal tube placement is confirmed or when a new intubating device is put in the
patients mouth after the previous device had been removed. Data collection includes the
timing and number of breaths given via Bag-Valve-Mask and patient repositioning between the
attempts. All treatments will be recorded. Data collection will continue until the patient is
discharged from the Emergency Department. The patient's diagnosis at the time of discharge
from the ED will be recorded. Patients' charts will be reviewed to determine the diagnosis,
occurrence of aspiration pneumonia, ICU length of stay, and inpatient length of stay. Two
attempts will be made to contact patients 28 days after study enrollment to determine their
condition at that time.
Data Analysis:
Data will be collected by a designated research assistant during the procedure and will then
be entered into an EXCEL (Microsoft Corp., Redmond, WA) database for storage. Data will be
exported into STATA 10.0 (STATA Corp., College Station, TX) for further analysis. The number
of attempts to successful intubation and total time to intubation will be compared using
descriptive statistics. Occurrence of hypoxia and aspiration pneumonia will be compared in
patients who were intubated with the C-MAC to patients intubated with standard laryngoscopy
using Chi-Square tests. Oxygen saturation, ETCO2, and heart rate will be compared in both
groups using multiple linear regression.
The length of stay and 28 day follow up between the two groups will be compared using
Wilcoxon rank sum tests. In order to detect a 15% difference in the length of stay between
the two groups, with a power of 80% and an alpha of 0.05, 100 patients will be required in
each group for a total of 200 patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03033251 -
High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02766946 -
Diaphragmatic Atrophy Related to Mechanical Ventilation
|
N/A | |
Completed |
NCT03780933 -
the Effect of High Dose Ascorbic Acid on Critically Ill Patients With ARDS
|
N/A | |
Withdrawn |
NCT04588441 -
The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19
|
Phase 2 | |
Completed |
NCT01928238 -
Physiologic Effects of Noninvasive Neurally Adjusted Ventilatory Assist (NAVA) Versus Noninvasive Pressure Support Ventilation in Patients at Risk for Respiratory Distress Needed Preventive Used of Noninvasive Ventilation After Extubation.
|
N/A |